Showing results (1071-1080 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|September 28, 2016
Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting SystemT Flaig, A Douros, E Bronder, et al.Journal of Clinical Pharmacy and Therapeutics|May 3, 2017
Ondansetron for neuraxial morphine-induced pruritus: A meta-analysis of randomized controlled trialsW Wang, L Zhou, L SunJournal of Clinical Pharmacy and Therapeutics|May 10, 2017
The impact of appointment-based medication synchronization on medication taking behaviour and health outcomes: A systematic reviewE Nguyen, D M SobierajJournal of Clinical Pharmacy and Therapeutics|May 27, 2018
CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamideO D Castelán-Martínez, C Hoyo-Vadillo, T B Bazán-Soto, et al.Journal of Clinical Pharmacy and Therapeutics|May 8, 2018
Correspondence between the CYP2C19 and CYP3A4 genotypes with the inferred metabolizer phenotype by omeprazole administration in Mexican healthy childrenA F Favela-Mendoza, G Martínez-Cortes, M M Romero-Prado, et al.Journal of Clinical Pharmacy and Therapeutics|May 8, 2018
Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysisJ Y Cui, R R Zhou, S Han, et al.Journal of Clinical Pharmacy and Therapeutics|April 16, 2018
Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysisA A Thakur, X Wang, M M Garcia-Betancourt, et al.Journal of Clinical Pharmacy and Therapeutics|September 1, 2016
Theophylline: a review of population pharmacokinetic analysesY J Ma, D Q Jiang, J X Meng, et al.Journal of Clinical Pharmacy and Therapeutics|September 1, 2016
Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsiaD-D Shi, F-Z Yang, L Zhou, et al.Journal of Clinical Pharmacy and Therapeutics|July 5, 2017
A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteersD Shin, Y Lee, H Kim, et al.Pageof 325